Jin Yang Pharmaceutical Co., Ltd. announces an Equity Buyback for 161,813 shares.
August 19, 2022 at 04:10 am EDT
Share
Jin Yang Pharmaceutical Co., Ltd. (KOSDAQ:A007370) announces a share repurchase program. Under the program, the company will repurchase up to 161,813 shares. The purpose of the program is stock price stability and shareholder value enhancement.
The program will expire on November 21, 2022. As of August 18, 2022, the company had 903,595 and 0 treasury stock holdings in acquisition within the range of dividends available and others, respectively.
JIN YANG PHARMACEUTICAL CO., LTD is a Korea-based company mainly engaged in the manufacturing and distributing of medicine and medicine supplies. The Companyâs products consist of drugs for the circulation systems, digestive organs and the central nervous systems, antibiotics, metabolic drugs, and others including antihistaminic agents, anti-inflammatory analgesic drugs, antimicrobials, muscle relaxants, psychotropic agents, high blood pressure medicines, diabetes medicines, injection medicines, skin disease medicines, nutritional supplements, anemia medicines, dental care drugs, ophthalmology care drugs and others. The Company distributes its products within domestic market and to overseas markets.
JIN YANG PHARMACEUTICAL CO., LTD. 
